Phase II Trial of Immunotherapeutic HPV Vaccine PRGN-2009 With Pembrolizumab Before Standard Treatment in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal Cancer
Condition: Oropharyngeal Squamous Cell Carcinoma (SCC) Interventions: Biological: PRGN-2009; Drug: Pembrolizumab Sponsor: National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 18, 2023 Category: Research Source Type: clinical trials
MUC1 Therapeutic Tumor Vaccine in Advanced Solid Cancers
Condition: Solid Tumor, Adult Intervention: Drug: Vaccine Sponsor: Peking Union Medical College Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials